Related Experiment Video
Updated: Jul 14, 2026

10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Th2 cytokines in susceptibility to tuberculosis
1Centre for Infectious Diseases and International Health (CIDIH), University College, London, UK. g.rook@ucl.ac.uk
Current Molecular Medicine
|May 17, 2007
Summary
Tuberculosis (TB) susceptibility in developing countries is linked to immune responses. Blocking the Th2 component, rather than just enhancing the Th1 response, may be key for effective vaccines where Bacillus Calmette et Guérin (BCG) often fails.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Tuberculosis (TB) remains a major global health challenge, particularly in developing countries where the Bacillus Calmette et Guérin (BCG) vaccine shows limited efficacy.
- Immune responses in these regions, characterized by a mixed IFN-gamma (Th1) and Th2 response to mycobacterial antigens, differ from those in areas with high BCG effectiveness.
- A pre-existing IL-4 (Th2) component appears to hinder immunity during active TB, especially after high-dose M. tuberculosis (Mtb) challenge.
Purpose of the Study:
- To investigate the immunological factors contributing to differential susceptibility to tuberculosis (TB) in developing countries.
- To understand why the BCG vaccine is less effective in these specific geographical and immunological contexts.
- To identify potential targets for novel TB vaccines tailored to populations where BCG fails.
Main Methods:
- Review and synthesis of existing data on immune responses (IFN-gamma, IL-4, IL-13, TNF-alpha) in individuals and animal models from developing countries.
- Analysis of the role of IL-4 and IL-13 in modulating Th1-mediated immunity and macrophage function.
- Examination of mechanisms by which IL-4 impacts antimicrobial activity, cell apoptosis, iron availability, and regulatory T cell proliferation.
Main Results:
- A background Th1 response may offer protection against low-dose Mtb challenge, but a pre-existing IL-4 response can impede immunity, particularly at higher challenge doses.
- IL-4 (and IL-13) can impair Th1 immunity by promoting alternative macrophage activation, reducing TNF-alpha-mediated apoptosis, decreasing iNOS activity, and increasing intracellular iron availability for Mtb.
- IL-4 also drives immunopathology through increased TNF-alpha toxicity and pulmonary fibrosis, and promotes the proliferation of FOXP-3+ regulatory T cells.
Conclusions:
- Effective TB vaccines for developing countries may require strategies that actively block the detrimental Th2 (IL-4/IL-13) immune responses, in addition to enhancing the Th1 response.
- Understanding and counteracting the suppressive effects of IL-4 is crucial for developing vaccines that confer protection in diverse populations.
- Targeting the Th2 component could overcome the limitations of current BCG vaccination strategies in high-incidence regions.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
